CNTX
Context Therapeutics Inc.NASDAQHealthcare$2.72+2.64%ClosedMarket Cap: $249.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.13
P/S
0.00
EV/EBITDA
-4.75
DCF Value
$0.67
FCF Yield
-9.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-47.0%
ROA
-52.7%
ROIC
-65.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-13.8M | $-13.0M | $-0.14 | — |
| FY 2025 | $0.00 | -Infinity% | $-39.7M | $-36.1M | $-0.38 | — |
| Q3 2025 | $0.00 | -Infinity% | $-10.6M | $-9.7M | $-0.10 | — |
| Q2 2025 | $0.00 | NaN% | $-9.8M | $-8.8M | $-0.09 | — |
| Q1 2025 | $0.00 | NaN% | $-5.5M | $-4.6M | $-0.05 | — |
| Q4 2024 | $0.00 | NaN% | $-4.3M | $-3.3M | $-0.06 | — |
| FY 2024 | $0.00 | NaN% | $-29.9M | $-26.7M | $-0.46 | — |
| Q3 2024 | $0.00 | NaN% | $-18.7M | $-17.5M | $-0.22 | — |
| Q2 2024 | $0.00 | NaN% | $-3.1M | $-2.3M | $-0.04 | — |
| Q1 2024 | $0.00 | NaN% | $-3.8M | $-3.7M | $-0.23 | — |
| Q4 2023 | $0.00 | NaN% | $-6.9M | $-6.8M | $-0.42 | — |
| FY 2023 | $0.00 | NaN% | $-25.1M | $-24.0M | $-1.50 | — |